Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden of Clostridioides difficile infection in a regional healthcare network by Rhea, S. et al.
RESEARCH ARTICLE
Modeling inpatient and outpatient antibiotic
stewardship interventions to reduce the
burden of Clostridioides difficile infection in a
regional healthcare network
Sarah RheaID
1*, Kasey Jones1, Stacy Endres-DigheID1, Breda Munoz1, David J. Weber2,
Rainer HilscherID
1, Jennifer MacFarquhar3,4, Emily Sickbert-Bennett2, Lauren DiBiase2,
Ashley Marx2,5, James Rineer1, James Lewis3, Georgiy Bobashev1, for the CDC MInD-
Healthcare Network¶
1 RTI International, Research Triangle Park, North Carolina, 2 UNC Health Care, Chapel Hill, North Carolina,
3 North Carolina Department of Health and Human Services, Raleigh, North Carolina, 4 Career
Epidemiology Field Officer Program, Division of State and Local Readiness, Center for Preparedness and
Response, Centers for Disease Control and Prevention, Atlanta, Georgia, 5 UNC Eshelman School of
Pharmacy, Chapel Hill, North Carolina
¶ Human subjects’ statement: This study was approved by the Institutional Review Boards at the University of
North Carolina at Chapel Hill and RTI International.
* srhea@rti.org
Abstract
Antibiotic exposure can lead to unintended outcomes, including drug-drug interactions,
adverse drug events, and healthcare-associated infections like Clostridioides difficile infec-
tion (CDI). Improving antibiotic use is critical to reduce an individual’s CDI risk. Antibiotic
stewardship initiatives can reduce inappropriate antibiotic prescribing (e.g., unnecessary
antibiotic prescribing, inappropriate antibiotic selection), impacting both hospital (health-
care)-onset (HO)-CDI and community-associated (CA)-CDI. Previous computational and
mathematical modeling studies have demonstrated a reduction in CDI incidence associated
with antibiotic stewardship initiatives in hospital settings. Although the impact of antibiotic
stewardship initiatives in long-term care facilities (LTCFs), including nursing homes, and in
outpatient settings have been documented, the effects of specific interventions on CDI inci-
dence are not well understood. We examined the relative effectiveness of antibiotic steward-
ship interventions on CDI incidence using a geospatially explicit agent-based model of a
regional healthcare network in North Carolina. We simulated reductions in unnecessary
antibiotic prescribing and inappropriate antibiotic selection with intervention scenarios at
individual and network healthcare facilities, including short-term acute care hospitals
(STACHs), nursing homes, and outpatient locations. Modeled antibiotic prescription rates
were calculated using patient-level data on antibiotic length of therapy for the 10 modeled
network STACHs. By simulating a 30% reduction in antibiotics prescribed across all inpa-
tient and outpatient locations, we found the greatest reductions on network CDI incidence
among tested scenarios, namely a 17% decrease in HO-CDI incidence and 7% decrease in
CA-CDI. Among intervention scenarios of reducing inappropriate antibiotic selection, we
found a greater impact on network CDI incidence when modeling this reduction in nursing
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homes alone compared to the same intervention in STACHs alone. These results support
the potential importance of LTCF and outpatient antibiotic stewardship efforts on network
CDI burden and add to the evidence that a coordinated approach to antibiotic stewardship
across multiple facilities, including inpatient and outpatient settings, within a regional health-
care network could be an effective strategy to reduce network CDI burden.
1. Introduction
Since 1978 when Clostridioides difficile (C. difficile) was first recognized as a cause of antibi-
otic-associated diarrhea and pseudomembranous colitis, C. difficile infection (CDI) has
become the most common healthcare-associated infection (HAI) in the United States and is
costly to the healthcare system [1]. Nonmodifiable CDI risk factors, like patient age and
comorbidities (e.g., organ transplant, chronic renal disease, inflammatory bowel disease) have
been described elsewhere [2]. However, a focus of prevention is to address established, modifi-
able CDI risk factors, specifically, exposure to antibiotics [2].
Exposure to antibiotics is associated with an increased risk of CDI [3]. Different antibiotics
are associated with different levels of CDI risk. A meta-analysis quantified the risk of develop-
ing CDI in hospitalized patients receiving particular classes of antibiotics compared to those
receiving no antibiotics [3]. Results from this meta-analysis support classification of clindamy-
cin (associated CDI odds ratio (OR) = 16.8, 95% confidence interval (CI) 7.5 to 37.8), carbape-
nems and any cephalosporin (OR = 5.7, 95% CI 2.1 to 15.2), and fluroquinolones (OR = 5.5,
95% CI 4.3 to 7.1) as “high risk” CDI antibiotics, while penicillin combinations (OR = 2.7, 95%
CI 1.8 to 4.2) and trimethoprim/sulfonamides (OR = 1.8, 95% CI 1.3 to 2.4) can be classified
as “moderate risk” CDI antibiotics [3]. Other antibiotics are considered lower risk for CDI [4].
The types of antibiotics prescribed and, therefore, the relative proportions of high-risk, moder-
ate-risk, and low-risk antibiotics prescribed, can vary across healthcare settings (i.e., inpatient
settings versus outpatient settings).
Improving antibiotic use is critical, not only to reduce an individual patient’s CDI risk, but
also to mitigate emerging antibiotic resistance [5]. In U.S. acute care hospitals, 30%–50% of all
prescribed antibiotics are considered inappropriate [6–11]. Inappropriate antibiotic prescrib-
ing can be defined as (1) unnecessary antibiotic prescribing (e.g., prescribing an antibiotic for
a viral infection); (2) inappropriate antibiotic selection (e.g., prescribing an antibiotic associ-
ated with a higher risk of CDI when a lower risk antibiotic would be as or more effective); (3)
inappropriate dose or duration of therapy; or (4) inappropriate antibiotic route of administra-
tion [12].
Efforts to reduce inappropriate antibiotic prescribing include antibiotic stewardship initia-
tives [13]. Antibiotic stewardship refers to a set of coordinated strategies designed to enhance
patient health outcomes, reduce resistance to antibiotics, and decrease unnecessary costs [14].
Historically, antibiotic stewardship initiatives have focused on inpatient settings, especially
within short-term acute care hospitals (STACHs). However, these efforts are expanding to
long-term care facilities (LTCFs) (i.e., nursing homes and long-term acute care hospitals
(LTACHs)) and outpatient settings in the community [13]. Antibiotic stewardship initiatives
aimed at reducing inappropriate antibiotic selection, and restricting exposure to CDI high-risk
antibiotics when lower risk antibiotics are appropriate, have proven effective in preventing
CDI within STACHs [15]. Although emerging evidence documents the impact of antibiotic
stewardship initiatives in LTCFs and in outpatient settings, the effects of specific interventions
in these settings on CDI incidence are not well understood [16, 17].
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The overall burden and transmission dynamics of C. difficile may be influenced by commu-
nity sources and person movement among healthcare facilities [18–20]. Given this intercon-
nectedness, a coordinated approach to antibiotic stewardship (i.e., implementation of
interventions at multiple facilities, rather than at individual facilities) across a regional health-
care network may be most effective in reducing the overall burden of CDI in a region.
Agent-based models (ABMs) can capture the complexities of person movement among
healthcare facilities and the communities they serve. Increasingly, ABMs are used to assess
HAI prevention interventions, including antibiotic stewardship, which can inform decision
making in public health and healthcare settings. Previous ABMs have demonstrated the reduc-
tion of CDI incidence associated with antibiotic stewardship initiatives in inpatient settings
[21] and the benefits of a coordinated approach to interventions across inpatient settings in
reducing incidence of CDI and other HAIs [22]. However, ABMs can also be used to estimate
the impact of antibiotic stewardship efforts in LTCFs and outpatient settings and the effect of a
coordinated antibiotic stewardship approach across regional healthcare networks.
We developed a geospatially explicit ABM of a regional healthcare network in North Caro-
lina (NC) capable of examining the relative effectiveness of antibiotic stewardship interven-
tions on CDI incidence [23]. We simulated reductions in unnecessary antibiotic prescribing
and inappropriate antibiotic selection with intervention scenarios at individual and network
healthcare facilities, including STACHs, LTCFs, and outpatient settings. Antibiotic exposure
assigned to agents located in the community was conceptualized as the agent being “pre-
scribed” the antibiotic at an outpatient healthcare facility. We estimated the effect of these
interventions on hospital (healthcare) onset (HO)- and community acquired (CA)-CDI inci-
dence trends across multiple simulations and discuss how this information could be used to
inform antibiotic stewardship efforts across a regional healthcare network.
2. Methods
This study was approved by the Institutional Review Boards at the University of North Caro-
lina at Chapel Hill and RTI International.
2.1 Regional healthcare network ABM with a CDI disease model
We previously developed a geospatially explicit ABM to simulate patient movement within a
major regional healthcare network in NC, UNC Health Care [23]. UNC Health Care provides
care for over 975,000 patients annually and is one of the largest healthcare systems in NC, with
a catchment area of 5.9 million people across 41 counties [24, 25]. The ABM includes an aca-
demic medical center (UNC Hospitals [929 total beds]) and 9 affiliate hospitals (ranging from
81 to 665 total beds) [26]. We used a baseline synthetic population of NC, constructed using
documented methods and code, which serve as agents for the ABM (S1 File) [23]. With a syn-
thetic population approach, our ABM is effectively tied to actual geographies and populations
and extends beyond single hospitals to include entire systems of communities and their associ-
ated healthcare networks [23]. Healthcare networks are groupings of related hospitals and
other healthcare facilities that may be based on geopolitical boundaries (e.g., states), catchment
areas (i.e., communities from which patients are drawn), and organizational structures (e.g.,
academic-affiliated medical campuses) [23].
Agents in the ABM represent >10.2 million NC residents [24]. Each agent can move
among STACHs, LTACHs, nursing homes, and the community. Agents located in the com-
munity node can be conceptualized to be anywhere in the community other than an STACH,
LTACH, or nursing home (e.g., home, outpatient healthcare facility). The ABM has a 1-day
timestep and 1-year time horizon.
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We updated the published ABM [23] by explicitly implementing 544 locations (i.e., location
nodes), as follows: 10 regional network UNC STACH nodes (i.e., UNC Hospitals and 9 affiliate
hospitals) [26]; 102 non-UNC STACH nodes (i.e., all 102 licensed STACHs in NC not affili-
ated with UNC Health Care) [27]; 421 nursing home nodes (representing the 421 NC licensed
nursing homes) [28]; 10 LTACH nodes (representing the 10 NC licensed LTACHs) [27]; and 1
community node. We parameterized agent movement among the 544 location nodes using (1)
de-identified patient-level data (UNC Health Care admissions during July 1, 2016─June 30,
2017), including length of stay (LOS); [23]; (2) publicly-available aggregate hospital discharge
data for NC [25, 29]; (3) published demographic characteristics of nursing home residents and
LTACH patients [30, 31]; (4) LOS distributions for nursing home patients according to Cen-
ters for Medicare & Medicaid Services (CMS) 2016 national patient-level fee-for-service claims
data for CMS beneficiaries (subsequently referred to as CMS 2016 data); and (5) publicly-avail-
able NC licensed healthcare facility characteristics (i.e., geographic location, capacity, occu-
pancy) [27, 30–33], as described in S1 File (see v. Process overview and scheduling). We
calibrated agent movement according to the CMS 2016 data using methods described previ-
ously [34] and in S1 File (see viv. Model verification, validation, and calibration).
We implemented a CDI disease model for each agent, with daily transition probabilities
between disease states [23]. In the CDI disease model, agents exist in one of the following four
disease states: susceptible, colonized, CDI, or dead (Fig 1). C. difficile asymptomatic coloniza-
tion was a necessary step to develop CDI [35]. Transitions between disease states were depen-
dent on an agent’s current location and other risk factors, including age, presence of
comorbidities, and antibiotic exposure [23, 36–38] (Table 1). Transition to colonization was
also dependent on the burden of colonization and CDI at the agent’s location (S1 File) [23,
38].
2.2 Modeling antibiotic exposure
Each agent in the ABM existed in a dynamic, binary state of antibiotic exposure (i.e., with anti-
biotic exposure [during the antibiotic course and for 90 days following the completion of the
course] or without antibiotic exposure). Daily probabilities of antibiotic exposure were
informed by agent location and age [38]. Antibiotic exposure assigned to agents located in
STACH, LTACH, or nursing home nodes was conceptualized as the agent being “prescribed”
the antibiotic at that healthcare facility. Antibiotic exposure assigned to agents located in the
community node was conceptualized as the agent being “prescribed” the antibiotic at an out-
patient healthcare facility.
We used patient-level data to calculate antibiotic prescribing rates and length of therapy
(LOT) per 1,000 patient-days in each of the seven network STACHs for which patient-level
data were available from UNC Health Care [39, 40]. LOT was selected as the antibiotic con-
sumption metric for this study, as it represents days of antibiotic exposure without regard to
the number of antibiotics used. Specifically, we defined LOT as the number of days that a
patient received systemic antibiotics during their admission (i.e., duration of antibiotic use),
regardless of the number of antibiotics received. For each of the three network STACHs for
Fig 1. Clostridioides difficile natural history states (CDI: Clostridioides difficile infection).
https://doi.org/10.1371/journal.pone.0234031.g001
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which patient-level data were not available, we assigned the mean LOT value of the network
STACH(s) in the same intensive care unit bed category [41, 42]. We selected categorization by
intensive care unit bed size, as it is commonly employed for HAI public health surveillance
activities [41, 42].
When an agent was assigned to antibiotic exposure, this assignment included (1) an antibiotic
course duration and (2) an antibiotic risk level (i.e., low-, moderate-, or high-risk antibiotic)
(Table 1). Agents with antibiotic exposure were at increased risk of CDI according to static risk
ratios (RRs) associated with each antibiotic risk level, selected to simulate varied risk correspond-
ing to different antibiotic classes, during the antibiotic course and for 90 days following the com-
pletion of the course [3, 4, 43, 44]. We used patient-level data from UNC Health Care to inform
the relative antibiotic risk level proportions applied to each location; each location’s proportion
of low-, moderate-, and high-risk antibiotics prescribed summed to one [38, 45]. Each agent’s
antibiotic-associated risk of CDI exponentially decreased during day 30 to day 90. No antibiotic-
associated CDI risk was modeled by day 91 following completion of antibiotic course (S1 File).
An agent could only be assigned a new course of antibiotics once it completed an existing
course. However, a new course could be initiated at any other time, including during the
90-day residual risk period. If an agent received a subsequent antibiotic assignment during the
residual risk period of a previously completed antibiotic course, the agent was assigned the
higher of the two possible antibiotic risk levels for the antibiotic course duration.
Table 1. Select1 Clostridioides difficile disease state and antibiotic parameter values.
Parameter Assumed value(s)2 Reference
CDI transmission rate by agent location (i.e.,
node location in ABM)
STACH and LTACH: 2.1x10-4 23
Nursing home: 8.6x10-5
Community: 6.3x10-6
Antibiotic prescribing rates for non-network
STACHs, LTACHs, nursing homes, and
outpatient locations3,4
Non-network STACH: 0.37 23
LTACH: 0.37
Nursing home: 0.005
Outpatient, <50 years of age: 1.3x103
Outpatient, 50–64 years of age: 1.4x103
Outpatient, �65 years of age: 1.7x103
Antibiotic course 10 days (SD = 2 days) Expert opinion
Antibiotic risk ratios Low risk: 2 3, 45
Moderate risk: 5
High risk: 12
Baseline relative proportion of antibiotic use
by risk class and location3,4
STACHs and LTACHs: proportion low
risk = 0.4, proportion moderate risk = 0.3,




Nursing homes and outpatient locations:
proportion low risk = 0.1, proportion
moderate risk = 0.6, proportion high risk = 0.3
ABM: Agent-based model; LTACH: long-term acute care hospital; SD: standard deviation; STACH: short-term acute
care hospital.
1See Appendix for additional parameter values.
2Assumed value rates are per day.
3Antibiotic exposure assigned to agents located in STACHs, LTACH, or nursing home nodes was conceptualized as
the agent being “prescribed” the antibiotic at that healthcare facility.
4Antibiotic exposure assigned to agents located in the community node was conceptualized as the agent being
“prescribed” the antibiotic at an outpatient location.
https://doi.org/10.1371/journal.pone.0234031.t001
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We calibrated the ABM to reproduce both colonization prevalence rates and antibiotic
exposure rates by location [23, 38, 46] (S1 File). Subsequently, we calibrated the ABM to repro-
duce the following CDI incidence targets: (1) HO-CDI according to NC-specific National
Healthcare Surveillance Network C. difficile lab event data by hospital; (2) published commu-
nity onset (CO)-CDI incidence [47–49]; (3) published CA-CDI incidence [50–53]; and (4)
published healthcare associated (HA)-CDI incidence [50–53]. We assigned a small number of
agents to transition CDI within their first 3 days of admission to a healthcare facility to meet
CO-CDI incidence calibration targets (S1 File). We used established CDI case definitions,
adapted to the context of this ABM, with each CDI case defined (1) as either CO-CDI or
HO-CDI and (2) as either CA-CDI or HA-CDI (S1 File). Specifically, we defined a CDI case
as CO-CDI if the agent transitioned to the CDI disease state fewer than 3 days after admission
to a healthcare facility (STACH, LTACH, nursing home), and HO-CDI if the agent transi-
tioned to the CDI disease state at least 3 days after admission to a healthcare facility (STACH,
LTACH, nursing home) [47]. Additionally, we defined a CDI case as CA-CDI if the agent tran-
sitioned to the CDI disease state while in the community node or within 3 days after admission
to a healthcare facility (STACH, LTACH, nursing home) and the agent had not been admitted
to a healthcare facility in the preceding 12 weeks; all CDI cases that did not meet these
CA-CDI criteria were classified as HA-CDI [51, 52]. We considered CDI cases that transi-
tioned to the CDI disease state between 2 and 8 weeks of the last CDI disease state transition to
be recurrent episodes and CDI cases that transitioned to the CDI disease state less than 2
weeks since the last CDI disease state transition to be duplicate episodes; all others were con-
sidered incident cases [51, 52].
2.3 Antibiotic stewardship interventions
We modeled two antibiotic stewardship interventions, each representing a decrease in inap-
propriate antibiotic use, as follows: (1) reduction in total antibiotics prescribed at individual
facility types alone and across all network facilities (i.e., coordinated stewardship approach)
(five scenarios total); (2) reduction in CDI high-risk antibiotics, in favor of CDI moderate-risk
antibiotics, prescribed at individual facility types (two scenarios total).
2.3.1. Reduction in total antibiotics prescribed. We developed five scenarios exploring
the impact of a reduction in antibiotics prescribed at individual healthcare facility types and
across healthcare facility types, representing a coordinated stewardship approach, as follows:
(1) network STACHs only; (2) nursing homes only; (3) outpatient facilities only; (4) all net-
work STACHs and nursing homes; and (5) all network inpatient and outpatient facilities (i.e.,
STACHs, nursing homes, LTACHs, and outpatient locations). For each scenario, the total
antibiotics prescribed were reduced by 10%, 20%, and 30%. Of note, across the network the
absolute decrease in the number of antibiotics prescribed differed with each of these scenarios.
For example, a 10% decrease in total antibiotics prescribed in STACHs and a 10% decrease in
total antibiotics prescribed in nursing homes are not equal in terms of the number of antibiotic
doses averted. We selected a 30% reduction as the maximum reduction possible in our simu-
lated interventions, as at least 30% of antibiotics prescribed in outpatient setting in the United
States are reportedly inappropriate [54].
2.3.2 Reduction in high-risk antibiotics prescribed. We developed two scenarios explor-
ing the impact of a reduction in high-risk antibiotics prescribed at individual facility types: (1)
network STACHs, and (2) nursing homes. For each scenario, the relative proportion of CDI
high-risk antibiotics was reduced by 0.1, with a concordant 0.1 increase in moderate-risk anti-
biotics prescribed, and by 0.2, with a concordant 0.2 increase in moderate-risk antibiotics
prescribed.
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We conducted 40 runs for each scenario using the entire NC synthetic population (>10.2
million agents) as microdata input to the ABM to account for the complex movement of agents
throughout the state. We defined the following model outcomes for the 41-county catchment
area of the network [23] to assess the relative effectiveness of each intervention, as follows:
HO-CDI incidence per 10,000 patient-days in network STACHs (i.e., the 10 STACHs of UNC
Health Care), HO-CDI incidence per 10,000 patient-days in nursing homes, HO-CDI inci-
dence per 10,000 patient-days in network inpatient healthcare facilities (i.e., 10 STACHs of
UNC Health Care, nursing homes, and LTACHs), and CA-CDI incidence per 100,000 popula-
tion. Incidence measures are presented as a mean, with range based on standard deviation and
95% CIs, of the multiple model runs. We calculated percent change in CDI incidence to com-
pare each intervention to baseline (i.e., no intervention), which corresponds to the data that
were used to design the ABM and reflects established antibiotic prescribing.
3. Results
3.1 Antibiotic prescribing rates in network STACHs
Antibiotic prescribing rates among admissions to the seven UNC STACHs for which data
existed (i.e., Hospitals 1–7) ranged from 251 LOT per 1,000 patient-days to 450 LOT per 1,000
patient-days (Table 2).
3.2 Reduction in total number of antibiotics prescribed
As the total number of antibiotics prescribed within network STACHs and nursing homes
decreased by 10%, 20%, and 30%, the HO-CDI incidence in the ABM also decreased within
that location category (Fig 2A and 2B). Specifically, as antibiotics prescribed in STACHs
decreased by 30%, the STACH HO-CDI incidence decreased by 10%, from 7.0 cases per
Table 2. Antibiotic prescribing rates and length of therapy (LOT) per 1,000 patient-days among admissions to
network short-term acute care hospitals (STACHs).




LOT per 1,000 patient
days
Hospital 1 10–19 0.45 450
Hospital 2 5–9 0.33 331
Hospital 3 20–42 0.25 251
Hospital 4 10–19 0.33 331
Hospital 5 5–9 0.33 332
Hospital 6 �43 0.28 281
Hospital 7 �43 0.29 290
Hospital 8 20–42 0.253 2513




1UNC Health Care STACH names are masked per data use agreement.
2Based on categories from following resource: N.C. Communicable Disease Branch. Healthcare-associated infections
in North Carolina. Reporting period: January 1–June 30, 2016. 2016 [cited July 31, 2019]. Raleigh, NC: N.C.
Surveillance for Healthcare-Associated and Resistant Pathogens Patient Safety (SHARPPS) Program. Available at
https://epi.dph.ncdhhs.gov/cd/hai/figures/2016/2016Q2_Hospital_Specific_Quarterly_Report.pdf
3Used Hospital 3 daily rate.
4Used mean of Hospitals 1 and 4 daily rates.
https://doi.org/10.1371/journal.pone.0234031.t002
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10,000 patient-days (95% CI 6.3–7.7 cases per 10,000 patient-days) to 6.3 cases per 10,000
patient-days (95% CI 5.6–7.0 cases per 10,000 patient-days) (Fig 2A). As the antibiotics pre-
scribed in nursing homes decreased by 30%, the nursing home HO-CDI incidence decreased
by 17%, from 8.4 cases per 10,000 patient-days (95% CI 7.1–9.8 cases per 10,000 patient-days)
to 7.0 cases per 10,000 patient-days (95% CI 5.9–8.2 cases per 10,000 patient-days) (Fig 2B).
As the total number of antibiotics prescribed in STACHs decreased by 30%, the network
HO-CDI incidence decreased by 2%, from 8.6 cases per 10,000 patient-days (95% CI 7.3–9.8
cases per 10,000 patient-days) to 8.4 cases per 10,000 patient-days (95% CI 7.2–9.6 cases per
10,000 patient-days) (Fig 2A). Similarly, as the antibiotics prescribed in nursing homes
decreased by 30%, network HO-CDI incidence decreased by 14%, to 7.4 cases per 10,000
patient-days (95% CI 6.3–8.4 cases per 10,000 patient-days) (Fig 2B). With a reduction in out-
patient antibiotics only, we observed a minimal reduction (1%) in CDI incidence at other net-
work locations (Fig 2C).
With a coordinated stewardship approach across all network STACHs and nursing homes
in the ABM, a 30% reduction in antibiotics prescribed resulted in a 17% decrease in network
HO-CDI incidence, to 7.1 cases per 10,000 patient-days (95% CI 6.1–8.1 cases per 10,000
patient-days) and a 3% decrease in CA-CDI incidence, from 122.8 cases per 100,000 person-
years (95% CI 108.8–136.8 per 100,000 person-years) to 119.6 cases per 100,000 person-years
(95% CI 105.9–133.2 per 100,000 person-years) (Fig 2D). With a coordinated stewardship
approach across all network inpatient and outpatient locations, reducing the antibiotics pre-
scribed by 30%, there was a 17% decrease in network HO-CDI incidence, to 7.1 cases per
10,000 patient-days (95% CI 6.1–8.1 cases per 10,000 patient-days) and a 7% decrease in
CA-CDI incidence, to 114.2 cases per 100,000 person-years (95% CI 101.0–127.3 cases per
100,000 person-years) in the ABM (Fig 2E).
With this intervention scenario, we observed occasional increases in CDI incidence. Specif-
ically, we observed a 0.1% increase in nursing home HO-CDI incidence with a 10% reduction
Fig 2. Clostridioides difficile infection (CDI) incidence and reductions in total number of antibiotics prescribed. Scenarios for reduction in total
number of antibiotics prescribed are as follows: (A) at network STACHs only; (B) at nursing homes only; (C) at outpatient facilities only; (D) at all
network STACHs and nursing homes; and (E) at all network inpatient (i.e., STACHs, nursing homes, LTACHs) and outpatient facilities. For each
scenario, the total antibiotics prescribed were reduced by 10%, 20%, and 30%. Results are based on 40 runs for each scenario. Error bars indicate 95%
confidence intervals on the percent change. (STACH: short-term acute care hospital; LTACH: long-term acute care hospital; HO-CDI: hospital
(healthcare) onset-CDI; CA-CDI: community associated-CDI).
https://doi.org/10.1371/journal.pone.0234031.g002
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in total antibiotics prescribed in network STACHs (Fig 2A). With 10% and 30% reductions in
total antibiotics prescribed in nursing homes, we observed 2% increases in STACH HO-CDI
incidence (Fig 2B). We observed a 1% increase in STACH HO-CDI incidence with a 20%
reduction in total antibiotics prescribed in outpatient facilities (Fig 2C).
3.3 Reduction in antibiotic risk
As the relative proportion of high-risk antibiotics prescribed in STACHs decreased by 0.2 (in
favor of moderate-risk antibiotics), the STACH HO-CDI incidence decreased by 14%, to 6.1
cases per 10,000 patient-days (95% CI 5.4–6.6 cases per 10,000 patient-days), and the network
HO-CDI incidence decreased by 2%, to 8.4 cases per 10,000 patient-days (95% CI 7.2–9.6
cases per 10,000 patient-days) (Fig 3A). Similarly, as the relative proportion of high-risk anti-
biotics prescribed in nursing homes decreased by 0.2 (in favor of moderate-risk antibiotics),
the nursing home HO-CDI incidence decreased by 8%, to 7.7 cases per 10,000 patient-days
(95% CI 6.5–8.9 cases per 10,000 patient-days), and the network HO-CDI incidence decreased
by 7%, to 7.9 cases per 10,000 patient-days (95% CI 6.8–9.1 cases per 10,000 patient-days) (Fig
3B). With a reduction in high-risk antibiotics prescribed in nursing homes, we observed a 1%
increase in STACH HO-CDI incidence and a 0.3% increase in CA-CDI incidence (Fig 3B).
4. Discussion
We implemented antibiotic stewardship interventions in a geospatially explicit ABM of a
regional healthcare network and examined the relative effectiveness of these interventions on
CDI incidence compared to baseline. Our ABM demonstrated relative changes in CDI inci-
dence based on simulated antibiotic stewardship initiatives to (1) reduce unnecessary antibiot-
ics at individual facility types compared to a coordinated approach across network locations;
and (2) reduce inappropriate antibiotic selection in STACHs and in nursing homes. Although
modest, the general trends in CDI incidence reduction and the relationships between imple-
mentation at individual facility types and other network locations are apparent.
We observed a greater impact on network HO-CDI by simulating a reduction in antibiotic
prescribing in nursing homes alone (14% HO-CDI reduction) compared to the same interven-
tion in STACHs alone (2% HO-CDI reduction). This finding is notable considering that the
absolute number of antibiotic courses prescribed in our ABM varies by healthcare facility type.
During a typical run of the ABM, the number of antibiotic courses initiated in STACHs is
approximately seven-times greater than the number of antibiotic courses initiated in nursing
homes. Therefore, a 30% reduction in total antibiotics administered in network STACHs is a
larger reduction in the absolute number of antibiotic doses than a 30% reduction in total anti-
biotics administered in nursing homes. However, the nursing home LOS (mean: 95 days) is
longer than the STACH LOS (range of means: 4.3–6.6 days) in the ABM (S1 File) [23]. Agents
in nursing homes are, therefore, at increased CDI risk for a longer time period compared to
agents at STACHs. Additionally, these agents who are prescribed antibiotics will likely remain
in a nursing home for most their antibiotic exposure time, increasing their CDI risk because of
facility-based transmission rates (S1 File) compared to agents discharged to their homes.
Finally, agents in nursing homes are inherently at increased risk of CDI due to their age (�65
years of age).
By simulating a reduction in inappropriate antibiotic selection, we estimated a relative
reduction in CDI high-risk antibiotics prescribed, in favor of moderate-risk antibiotics, in
STACHs and nursing homes. In these simulations, the interventions focused at nursing homes
alone resulted in a larger impact on CDI incidence, compared to similar interventions at net-
work STACHs alone. Again, this finding can largely be explained by the longer LOS for agents
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in nursing homes, compared to STACHs, in the ABM and their inherent increased risk of CDI
due to age.
With each of the two antibiotic stewardship interventions modeled, we observed occasional
simulation results of increased CDI incidence. For the intervention scenario of reducing total
antibiotics prescribed, these observations were inconsistent across percent reductions (Fig 2A,
2B and 2C). For example, 10%, 20%, and 30% reductions in total antibiotics prescribed in
nursing homes resulted in a 2% increase, a 2% decrease, and a 2% increase, respectively, in
STACH HO-CDI incidence (Fig 2B). Similarly, the greater the reduction in high-risk antibiot-
ics prescribed in nursing homes, the smaller the increase in STACH HO-CDI incidence (Fig
3B). This may be related to random variation during simulations. In the future, we will con-
sider conducting additional simulation runs, beyond the 40 simulation runs presented here, to
further investigate this variation.
Fig 3. Clostridioides difficile infection (CDI) incidence and reductions in high-risk antibiotics prescribed.
Scenarios as follows: (A) at network STACHs only; and (B) at nursing homes only. For each scenario, the relative
proportion of CDI high-risk antibiotics was reduced by 0.1, in favor of a 0.1 increase in moderate-risk antibiotics
prescribed, and by 0.2, in favor of a 0.2 increase in moderate-risk antibiotics prescribed. Results are based on 40 runs
for each scenario. Error bars indicate 95% confidence intervals on the percent change. (STACH: short-term acute care
hospital; HO-CDI: hospital (healthcare) onset-CDI; CA-CDI: community associated-CDI).
https://doi.org/10.1371/journal.pone.0234031.g003
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Among our interventions for reduced antibiotic prescribing, we found a maximum impact
on CDI incidence when modeling the intervention across all network inpatient and outpatient
locations, with a 17% reduction in network HO-CDI incidence and a 7% reduction in
CA-CDI incidence. These results support a coordinated approach to antibiotic stewardship
across multiple facilities and facility types as an effective strategy to reduce the burden of CDI
in regional healthcare networks [55, 56].
This modeling study is unique in considering outpatient prescribing, conceptualized as
agents located in the community node being “prescribed” the antibiotic at an outpatient loca-
tion. Healthcare facilities within a network are interconnected with each other and their catch-
ment areas through person movement. By including the community in our ABM, this study
brings an enhanced understanding of the potential impact of antibiotic stewardship interven-
tions on CDI incidence in the community. This not only provides additional nuance to our
interpretations but also makes the ABM more realistic, which could aid in translation of find-
ings to public health and healthcare stakeholders, especially those who are unfamiliar with
ABMs.
We calculated daily antibiotic prescribing rates at network STACHs using patient-level data
from UNC Health Care, which varied slightly across facility intensive care unit bed categories.
Although the impact of this variability is not established, future work could include evaluating
the sensitivity of the model output to variable daily prescribing rates across different healthcare
facility types (e.g., tertiary care versus critical access STACH). Further, these daily prescribing
rates could be informed by data from other healthcare systems in other regions.
There are several limitations to the study. Our results suggest modest relative effects that
make some scenario comparisons challenging to interpret. For example, a reduction in antibi-
otics prescribed at STACHs alone resulted in a 14% reduction in STACH HO-CDI incidence,
while a reduction in antibiotics prescribed across all network locations produced only an 11%
reduction in STACH HO-CDI incidence. This counterintuitive finding can be explained by
the negligible difference between the actual HO-CDI incidence values, which are quite similar
over the 40 model simulations (6.0 cases per 10,000 patient-days and 6.2 cases per 10,000
patient-days, respectively). This may also be related to random variation during simulations or
to the antibiotic assignment rules that we employed (e.g., an agent could only be assigned a
new course of antibiotics once it completed an existing course). In the future, we will consider
conducting additional simulation runs, beyond the 40 simulation runs presented here, to fur-
ther investigate this variation. Although community administration of antibiotics did not
increase the likelihood that an agent was transferred to a healthcare facility, this update could
be implemented in subsequent iterations of the ABM. Finally, other types of models (e.g.,
deterministic differential equation model) could arguably be used to evaluate antibiotic stew-
ardship interventions as presented in this manuscript. However, we view these interventions
and our results as initial steps in our effort to use this ABM to study a variety of simulated
interventions as follow-on studies.
We employed the antibiotic stewardship interventions uniformly across all 10 network
STACHs, but this does not impart the maximum possible variation that the ABM can provide
across these 10 sites. Similarly, outpatient prescribing was treated uniformly across the com-
munity location node. However, variability in outpatient prescribing varies by geography and
facility type [46]. We assumed that the interventions were implemented with perfect specific-
ity, only reducing inappropriate antibiotic prescribing and not appropriate antibiotic
prescribing.
We evaluated the two antibiotic stewardship interventions independently. Realistically,
these interventions would be applied in coordination and to varying degrees across individual
facilities and multiple facilities, as stewardship efforts should be directed toward the most
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relevant factors applicable to that setting [57]. Future simulations will address these limitations
by accounting for variability in prescribing practices across locations and by exploring imple-
mentation of antibiotic stewardship interventions at single STACHs of different types (e.g.,
tertiary care, critical access) on incidence of C. difficile and other HAI pathogens. We concep-
tualized reduction of inappropriate antibiotic use as shifts from higher-risk to moderate-risk
CDI antibiotics. The impact of successful antibiotic stewardship efforts at different facility
types will lead to greater variation in proportions of low, moderate, and high-risk CDI antibi-
otics than was modeled in this study.
All antibiotic prescribers and healthcare facilities are responsible for antibiotic stewardship
efforts. This responsibility includes a determination if antibiotics are necessary and, if so, the
optimal antibiotic selection, dose, duration, and route [12]. Antibiotic stewardship efforts may
be maximized if implemented across multiple healthcare facilities serving a population. Our
findings build on the established modeling literature that supports the effectiveness of a coor-
dinated approach for antibiotic stewardship across multiple facilities. This study also uniquely
demonstrates the added impact of antibiotic stewardship interventions in LTCF and outpa-
tient locations across a regional healthcare network for a reduction in the burden of HAIs.
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